Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

OSI-774 (Tarceva) in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

This study has been completed.
NCIC Clinical Trials Group
Information provided by:
Astellas Pharma Inc Identifier:
First received: May 13, 2002
Last updated: June 12, 2015
Last verified: June 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2003
  Estimated Primary Completion Date: No date given